[Optimal dosage of orotic acid in the treatment of toxic hyperbilirubinemia in premature infants].
D000284:Administration, Oral; D001663:Bilirubin / Q000097:blood; D001724:Birth Weight; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006932:Hyperbilirubinemia / Q000188:drug therapy*; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D009963:Orotic Acid / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use
D009963:Orotic Acid; D001663:Bilirubin
Optimale Orotsäuredosierung zur Verhütung der toxischen hyperbilirubinämie Frühgeborener.